- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/569 - Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Patent holdings for IPC class G01N 33/569
Total number of patents in this class: 10893
10-year publication summary
763
|
761
|
810
|
782
|
768
|
1001
|
1107
|
995
|
827
|
72
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 19503 |
124 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2832 |
107 |
Immatics Biotechnologies GmbH | 1170 |
102 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3352 |
72 |
bioMerieux | 927 |
67 |
Institut Pasteur | 789 |
67 |
Centre National de La Recherche Scientifique | 10091 |
66 |
President and Fellows of Harvard College | 5911 |
66 |
The General Hospital Corporation | 4645 |
61 |
Labrador Diagnostics LLC | 281 |
60 |
The Johns Hopkins University | 5529 |
54 |
Denka Company Limited | 2458 |
54 |
Vanderbilt University | 1816 |
54 |
Massachusetts Institute of Technology | 9912 |
52 |
Becton, Dickinson and Company | 7063 |
51 |
Memed Diagnostics Ltd. | 78 |
49 |
IDEXX Laboratories, Inc. | 779 |
47 |
Laboratory Corporation of America Holdings | 756 |
44 |
Board of Regents, The University of Texas System | 5613 |
43 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2608 |
40 |
Other owners | 9613 |